Yasuhiro Hayashi Selected Research

Yasuhiro Hayashi Research Topics

Disease

5	Anemia 04/2022 - 01/2021
5	Inflammation (Inflammations) 08/2021 - 06/2009
4	Hypoxia (Hypoxemia) 12/2021 - 01/2021
4	Infections 10/2021 - 07/2012
4	Type 2 Diabetes Mellitus (MODY) 03/2014 - 12/2006
3	Neoplasms (Cancer) 01/2022 - 06/2011
2	Chronic Renal Insufficiency 01/2021 - 01/2021
2	Embolism (Embolus) 08/2020 - 03/2020
2	Stroke (Strokes) 08/2020 - 03/2020
2	Atrial Fibrillation 08/2020 - 03/2020
2	Hemorrhage 08/2020 - 03/2020
2	Edema (Dropsy) 09/2014 - 06/2009
2	Hepatitis 10/2012 - 10/2009
2	Optic Nerve Diseases (Optic Neuropathy) 07/2011 - 08/2009
1	Breast Neoplasms (Breast Cancer) 01/2022
1	Neoplasm Metastasis (Metastasis) 01/2022
1	Virus Diseases (Viral Diseases) 10/2021
1	COVID-19 10/2021
1	Pain (Aches) 08/2021
1	Myocardial Infarction 08/2020
1	Hypertension (High Blood Pressure) 03/2020
1	Adrenoleukodystrophy (Adrenoleukodystrophy, X-Linked) 01/2020
1	Chromosome Aberrations (Chromosome Abnormalities) 01/2019
1	Fatty Liver 03/2016
1	Fibrosis (Cirrhosis) 03/2016
1	Non-alcoholic Fatty Liver Disease 03/2016
1	Asthma (Bronchial Asthma) 09/2014
1	Obesity 03/2014
1	Overweight 03/2014
1	Disease Progression 03/2014
1	Metabolic Diseases (Metabolic Disease) 03/2014
1	Atrophic Gastritis 03/2014
1	Stomach Ulcer (Gastric Ulcer) 03/2014
1	Dysbiosis 03/2014
1	Peritonitis 01/2013
1	Mitochondrial Diseases (Mitochondrial Disease) 01/2013

Drug/Important Bio-Agent (IBA)

5	molidustatIBA 04/2022 - 01/2021
4	EnzymesIBA 01/2022 - 03/2014
4	Prolyl-Hydroxylase InhibitorsIBA 12/2021 - 01/2021
4	LipidsIBA 10/2021 - 06/2011
4	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 07/2011 - 06/2009
3	HematinicsIBA 12/2021 - 01/2021
3	Pharmaceutical PreparationsIBA 10/2021 - 09/2003
3	Phosphoric Diester Hydrolases (Phosphodiesterases)IBA 05/2010 - 06/2009
3	Insulin (Novolin)FDA Link 01/2010 - 12/2006
2	Erythropoietin FDA Link 01/2021 - 01/2021
2	RivaroxabanIBA 08/2020 - 03/2020
2	Small Interfering RNA (siRNA)IBA 03/2014 - 06/2011
2	AcidsIBA 03/2014 - 12/2008
2	Peptides (Polypeptides)IBA 10/2012 - 03/2008
2	1- cyclohexyl- N- (6- (4- hydroxy- 1- piperidinyl)- 3- pyridinyl)- 3- methyl- 1H- thieno(2,3- c)pyrazole- 5- carboxamideIBA 05/2010 - 06/2009
2	DNA (Deoxyribonucleic Acid)IBA 01/2010 - 04/2007
1	Serine Proteases (Serine Protease)IBA 01/2022
1	Platelet Activating FactorIBA 01/2022
1	Cathepsin GIBA 01/2022
1	1-Alkyl-2-acetylglycerophosphocholine Esterase (PAF Acetylhydrolase)IBA 01/2022
1	SphingolipidsIBA 10/2021
1	SARS-CoV-2 spike proteinIBA 10/2021
1	FenretinideIBA 10/2021
1	dihydroceramideIBA 10/2021
1	safingol (sphinganine)IBA 10/2021
1	retinamideIBA 10/2021
1	LipopolysaccharidesIBA 08/2021
1	CreatinineIBA 03/2020
1	AnticoagulantsIBA 03/2020
1	Acyl Coenzyme A (Acyl CoA)IBA 01/2020
1	Oxygen (Dioxygen)IBA 01/2019
1	CholesterolIBA 03/2016
1	Carbon Tetrachloride (Tetrachloromethane)IBA 03/2016
1	3- (1- (4- phenoxyphenyl)- 3- (2- phenylethyl)- 1H- indol- 5- yl)propanoic acidIBA 03/2016
1	PropaneIBA 03/2016
1	PropionatesIBA 03/2016
1	SaltsIBA 03/2016
1	Group IV Phospholipases A2IBA 03/2016
1	LigandsIBA 07/2015
1	SphingomyelinsIBA 10/2014
1	phorbolIBA 09/2014
1	Acetates (Acetic Acid Esters)FDA Link 09/2014
1	OvalbuminIBA 09/2014
1	Blood Glucose (Blood Sugar)IBA 03/2014
1	MonoglyceridesIBA 03/2014
1	AcyltransferasesIBA 03/2014
1	Triglycerides (Triacylglycerol)IBA 03/2014
1	UreaseIBA 03/2014
1	Fatty Acids (Saturated Fatty Acids)IBA 01/2013
1	Peptide Hydrolases (Proteases)FDA Link 01/2013
1	1-O-hexadecyl-2-N-methylcarbamol -sn-glycerol-3-phosphocholineIBA 01/2013
1	ZymosanIBA 01/2013
1	Caspase 3 (Caspase-3)IBA 01/2013
1	Caspase 9IBA 01/2013
1	octaarginineIBA 10/2012
1	Hepatocyte Growth Factor (Growth Factor, Hepatocyte)IBA 10/2012
1	GalactosamineIBA 10/2012
1	Granzymes (Granzyme)IBA 07/2012
1	ThioredoxinsIBA 07/2011
1	Lipid NanoparticlesIBA 06/2011
1	Tuberculin (PPD)IBA 06/2011

Therapy/Procedure

2	Renal Dialysis (Hemodialysis) 12/2021 - 11/2002
1	Peritoneal Dialysis 04/2022
1	Traditional Medicine (Folk Remedies) 08/2021